spacer
home > pmps > summer 2008 > special dispensation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Special Dispensation

Pressure is increasing on today’s pharmaceutical industry to implement more reliable and consistent safeguards against mistakes in dispensing medication, whether from contamination, mixing up drugs or inappropriate dosing. As a result, pharmaceutical companies are turning to non-destructive testing (NDT) techniques for product and packaging inspection.

A number of these techniques have already been adopted, including the use of optical, infra-red, ultrasound, vacuum decay and x-ray inspection methods. Traditionally, these have primarily been used for batch control through various batch sampling and inspection strategies. However, there is increasing demand for in-line inspection of all products, particularly where they have high commercial value or involve high dosage levels.

Applications for in-line NDT of products are as varied as the products themselves. Typical inspection scenarios may entail: checking fill levels in bottles and tubs of drugs, in liquid, powder, and even tablet forms; checking for missing tablets in blister packs; detecting contaminants (such as metal or glass) in dressings; and checking for correctly assembled devices.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Martin Allen graduated from Nottingham University with an Honours Degree in Geology in 1989 and gained a Doctorate in Engineering in 1993, specialising in image processing and analysis. After two years of developing an advanced document imaging system, Martin joined the software department of OIS Engineering in 1996. Some 11 years later, OIS has become Shaw Inspection Systems, and Martin has become a leading expert in both digital radiography (DR), and computed tomography (CT). He now heads the software department and is responsible for current research and development into both DR and CT.
spacer
Martin Allen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PAREXEL INTERNATIONAL ANNOUNCES ACQUISITION OF ATLAS MEDICAL SERVICES, A PROVIDER OF CLINICAL RESEARCH SERVICES IN TURKEY

London, UK, July 2, 2014 – PAREXEL International Corporation (Nasdaq: PRXL)(“PAREXEL” or the “Company”), a global clinical research organisation, announced today that the Company has acquired all of the outstanding equity securities of ATLAS Medical Services (“ATLAS”), a provider of clinical research services in Turkey, the Middle East, and North Africa.
More info >>

White Papers

Autoinjectors From Planning to Launch

SHL Group

Looking at the rising trend towards self-administration therapies, injectable drug delivery devices such as pen injectors, autoinjectors and needle free injectors show a significant growth potential in the near future. In 2010, the pen systems and autoinjectors market was estimated to be worth over $0.58bn, a growth of 8-10% from previous years. It is estimated that the market will continue to grow steadily between 10-15% over the forecast period. It will reach $0.87bn in 2013 and $1.07bn in 2015. (Visiongain, June, 2011)
More info >>

 
Industry Events

Advances in Cancer Immunotherapies 2014 (ACI2014)

15-16 October 2014, Singapore

Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year, making cancer a new global pandemic with huge economic impact on the healthcare industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement